80 likes | 80 Views
Market Overview:<br>According to a new market research study titled u2018In-Vitro Diagnostics Market - Global Analysis and Forecasts by Product & Services, Technology, Application, and End User. The global In-Vitro Diagnostics market is expected to reach US$ 107,658.83 Mn in 2027 from US$ 68,608.16 Mn in 2019. The market is estimated to grow with a CAGR of 5.8% from 2020-2027. The report highlights the trends prevalent in the global In-Vitro Diagnostics market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to rising prevale
E N D
In-Vitro Diagnostics Market Global Analysis and Forecast to 2028 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services), Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others), and Geography 2
Email: sales@theinsightpartners.com In-Vitro DiagnosticsMarket Overview The in-vitro diagnostics market was valued at US$ 63,746.63 million in 2019 and it is projected to reach US$ 90,656.80 million by 2027; it is expected to grow at a CAGR of 4.5% from 2020 to 2027. The report highlights the trends prevalent in the global In-Vitro Diagnostics market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to rising prevalence of chronic diseases, increasing geriatric population, and rising awareness regarding healthcare. However, lack of healthcare infrastructure and reimbursement policies are likely to pose a negative impact on the market growth. 3
Email: sales@theinsightpartners.com Key Segment Market Segment :- By Product and Services (Reagents and Kits, Instruments, and Software and Services) Technology (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others) Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others), and Geography 4
Email: sales@theinsightpartners.com $50,000 In-Vitro Diagnostics Market Value $40,000 $30,000 CAGR of 4.5% $20,000 (2020-2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles F. Hoffmann-la Roche Ltd. Danaher Abbott Siemens AG Sysmex Corporation Thermo Fisher Scientific, Inc. BD Biomérieux SA Bio-Rad Laboratories, INC. Qiagen 6 Download Sample Here
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com